Login / Signup

Toll-Like Receptor 3 as a Recurrence Risk Factor and a Potential Molecular Therapeutic Target in Colorectal Cancer.

Tatsuya YoshidaTakuya MiuraTomoh MatsumiyaHidemi YoshidaHajime MorohashiYoshiyuki SakamotoAkira KuroseTadaatsu ImaizumiKenichi Hakamada
Published in: Clinical and experimental gastroenterology (2020)
Non-expression of TLR3 in CRC cells was associated with lymph node metastasis and was an independent risk factor for recurrence. These results suggest that TLR3 may not only be used as a prognostic factor and a risk factor for recurrence, but further studies on the involvement of TLR3 with tumor growth may provide new therapeutic strategies.
Keyphrases